Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 14, Issue 8
Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Case report
Bullous fixed drug eruption following administration of the recombinant adjuvant Shingrix vaccine
Online download statistics by month:
Online download statistics by month: August 2021 to July 2022
Abstract
Full
Pdf
Aug 2021
308
308
43
Sep 2021
372
367
54
Oct 2021
170
161
34
Nov 2021
122
119
28
Dec 2021
67
60
30
Jan 2022
56
53
25
Feb 2022
69
63
43
Mar 2022
85
82
28
Apr 2022
76
76
16
May 2022
72
72
30
Jun 2022
212
209
11
Jul 2022
2
1
1
Total
1611
1571
343
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF